News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Biotech Was "Late To The Party, But Partied Hard" -- And Beware The Hangover



11/1/2016 8:29:54 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
The IBB, an ETF that tracks biotech stocks, has fallen nearly 11 percent this month — and could be headed lower.

"To us, this is really a story about market sentiment," Max Wolff, market strategist at 55 Capital, said Friday on CNBC's "Trading Nation."

Biotech is a high-risk space that shot up quickly, Wolff said. The iShares Nasdaq Biotechnology ETF, the IBB, hit an all-time high last summer and has since tumbled as drug manufacturers' pricing has come under scrutiny. The presidential election has weighed on the space, too; biotech rallies have suffered after remarks made by Democratic candidate Hillary Clinton addressing drug pricing.

Read at CNBC


comments powered by Disqus
CNBC
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES